
Pfizer is facing a shortage of penicillin due to increased demand and more diagnoses of syphilis, the company said in a letter to its customers this week.
The company said there is an "impending stock out situation" for select Bicillin L-A and Bicillin C-R prefilled syringes, Pfizer's brand name of injectable penicillin.